DOI:

Discover the new country in the Valve for Life initiative, Portugal.

Discover the new country in the Valve for Life initiative, Portugal.

Keep up to date on what has been achieved so far, the challenges and expectations for 2017

Rui Campante Teles, APIC President

The Portuguese population is one of the oldest in Europe. Currently, there are around one million individuals over the age of 75. Around 3.4% of this population present with severe aortic stenosis, with about 75% being symptomatic. It is estimated that in 2015 only about 19% of potential beneficiaries actually received TAVI, and the TAVI/AVR ratio is as low as 1:6 compared to several other European countries which have already reached rates of 1:1.

There were 27 catheterisation laboratories in Portugal in 2016 with 95% of the TAVI activity performed in public hospitals. Most centres with fully operational catheterisation laboratories are part of the public health system and are thus financed by the yearly state budget for healthcare.

After the launch of the Valve for Life initiative in 2015 in Poland and France, it was decided to extend the initiative to Portugal at the beginning of 2017 under the umbrella of the Portuguese Society of Cardiology. The Oversight Committee of the initiative is confident that it can promote the use of this technology in Portugal, increasing the number of TAVI procedures. The efforts of this initiative seem promising and the prospect of duplicating the success of the other participating countries seems realistic.

In Portugal, one of the first objectives of the initiative will be to raise public awareness of the symptoms of valvular heart disease and aortic stenosis while underlining the benefits of currently available treatments. This will allow an increase in the diagnosis of the disease, eventually helping to improve access to treatment. At the same time, it will ensure hospital and cathlab capacity and funding while increasing research and analysis of scientific evidence, including clinical studies for approaches to sedation. A variety of surveys will be undertaken along with a public media campaign. Educational and other meetings and events will be planned. We are also in contact with the Portuguese Medical Association and engaged in meeting with the relevant state health officials.

Rui Campante Teles, FESC

President, APIC- Associação Portuguesa de Intervenção Cardiovascular

VFL Champions: Lino Patrício and Rui Campante Teles

Contact details: APIC - Associação Portuguesa de Intervenção Cardiovascular, Campo Grande 28, 13º, 1700-093 Lisboa, Portugal

E-mail: [email protected]

Webpage: www.valveforlife.pt

NEWS

The spotlight for the ESC Congress 2017 is on “40 years of PCI”! Young clinicians can submit their clinical cases by 1 March 2017 with the late-breaking science submissions open early March. Check it out!

Join the EAPCI Young LinkedIn group: boost your network and stay informed on educational opportunities all year long!

Learn more on EAPCI and its activities on: www.escardio.org/eapci

Volume 12 Number 14
Feb 20, 2017
Volume 12 Number 14
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00052 Nov 18, 2024
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off
Webb J and Offen S
free

Debate

10.4244/EIJ-E-24-00054 Nov 18, 2024
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons
Rodés-Cabau J et al
free

EAPCI Column

Nov 18, 2024
EAPCI at PCR London Valves 2024
free

Original Research

10.4244/EIJ-D-24-00442 Nov 18, 2024
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis
Cardaioli F et al
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved